Olokizumab in patients with inflammatory phenotype of osteoarthritis, treatment experience

Olokizumab in patients with inflammatory phenotype of osteoarthritis, treatment experience

Objective: to investigate the efficacy and safety of olokizumab (OKZ) in patients with knee osteoarthritis (OA) with synovitis, persistent pain and ineffectiveness of previous conservative therapy.   Material and methods. The study included 15 patients with stage II–III knee OA who fulfilled the ACR...

Full description

Bibliographic Details
Main Authors: A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, E. P. Sharapova, E. A. Strebkova, N. M. Savushkina, A. R. Khalmetova, V. A. Nesterenko, A. S. Avdeeva, E. Yu. Samarkina, M. E. Diatroptov, O. G. Alekseeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-06-01
Series:Современная ревматология
Subjects:
osteoarthritis
inflammatory phenotype
interleukin 6
olokizumab
Online Access:https://mrj.ima-press.net/mrj/article/view/1584

Internet

https://mrj.ima-press.net/mrj/article/view/1584

Similar Items